Genetic modifiers of Duchenne muscular dystrophy (DMD) are variants located in genes different from the disease-causing gene DMD, but associated with differences in disease onset, progression, or response to treatment. Modifiers described so far have been tested mainly for associations with ambulatory function, while their effect on upper limb function, which is especially relevant for quality of life and independence in non-ambulatory patients, is unknown. We tested genotypes at several known modifier loci (SPP1, LTBP4, CD40, ACTN3) for association with Performance Upper Limb version 1.2 score in an Italian multicenter cohort, and with Brooke scale score in the Cooperative International Neuromuscular Group Duchenne Natural History Study (CINRG-DNHS), using generalized estimating equation (GEE) models of longitudinally collected data, with age and glucocorticoid treatment as covariates. CD40 rs1883832, previously linked to earlier loss of ambulation, emerged as a modifier of upper limb function, negatively affecting shoulder and distal domains of PUL (p = 0.023 and 0.018, respectively) in the Italian cohort, as well as of Brooke score (p = 0.018) in the CINRG-DNHS. These findings will be useful for the design and interpretation of clinical trials in DMD, especially for non-ambulatory populations.

Genetic modifiers of upper limb function in Duchenne muscular dystrophy / D. Sabbatini, A. Fusto, S. Vianello, M. Villa, J. Janik, G. D'Angelo, E. Diella, F. Magri, G.P. Comi, C. Panicucci, C. Bruno, A. D'Amico, E. Bertini, G. Astrea, R. Battini, L. Politano, R. Masson, G. Baranello, S.C. Previtali, S. Messina, G. Vita, A. Berardinelli, T. Mongini, A. Pini, M. Pane, E. Mercuri, E.P. Hoffman, L. Morgenroth, H. Gordish-Dressman, T. Duong, C.M. Mcdonald, L. Bello, E. Pegoraro. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - 269:9(2022), pp. 4884-4894. [10.1007/s00415-022-11133-8]

Genetic modifiers of upper limb function in Duchenne muscular dystrophy

G. D'Angelo;F. Magri;G.P. Comi;C. Bruno;
2022

Abstract

Genetic modifiers of Duchenne muscular dystrophy (DMD) are variants located in genes different from the disease-causing gene DMD, but associated with differences in disease onset, progression, or response to treatment. Modifiers described so far have been tested mainly for associations with ambulatory function, while their effect on upper limb function, which is especially relevant for quality of life and independence in non-ambulatory patients, is unknown. We tested genotypes at several known modifier loci (SPP1, LTBP4, CD40, ACTN3) for association with Performance Upper Limb version 1.2 score in an Italian multicenter cohort, and with Brooke scale score in the Cooperative International Neuromuscular Group Duchenne Natural History Study (CINRG-DNHS), using generalized estimating equation (GEE) models of longitudinally collected data, with age and glucocorticoid treatment as covariates. CD40 rs1883832, previously linked to earlier loss of ambulation, emerged as a modifier of upper limb function, negatively affecting shoulder and distal domains of PUL (p = 0.023 and 0.018, respectively) in the Italian cohort, as well as of Brooke score (p = 0.018) in the CINRG-DNHS. These findings will be useful for the design and interpretation of clinical trials in DMD, especially for non-ambulatory populations.
CD40; Duchenne muscular dystrophy; Genetic modifiers; SPP1–osteopontin; Upper limb function
Settore MED/26 - Neurologia
Article (author)
File in questo prodotto:
File Dimensione Formato  
415_2022_Article_11133.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.37 MB
Formato Adobe PDF
2.37 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/934613
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact